anti-inflammatory and skin protective properties of Virgin coconut oil.

Journal: Journal of traditional and complementary medicine
Published Date:

Abstract

Virgin coconut oil (VCO) has been traditionally used as moisturizer since centuries by people in the tropical region. Clinical studies have revealed that VCO improves the symptoms of skin disorders by moisturizing and soothing the skin. However, the mechanistic action of VCO and its benefits on skin has not been elucidated . The cytotoxicity (CTC) of VCO was 706.53 ± 2.1 and 787.15 ± 1.1 μg/mL in THP-1 (Human monocytes) and HaCaT (Human keratinocytes) cells respectively. VCO inhibited TNF-α (62.34 ± 3.2 %), IFN-γ (42.66 ± 2.9 %), IL-6 (52.07 ± 2.0 %), IL-8 (53.98 ± 1.8 %) and IL-5 (51.57 ± 2.6 %) respectively in THP-1 cells. Involucrin (INV) and filaggrin (FLG) content increased by 47.53 ± 2.1 % and 40.45 ± 1.2 % respectively in HaCaT cells. VCO increased the expression of Aquaporin-3 (AQP3), involucrin (INV) and filaggrin (FLG) and showed moderate UV protection in HaCaT cells. skin irritation studies in Reconstructed human epidermis (RHE) and NIH3T3 cells showed that VCO is a non skin irritant (IC > 1000 μg/mL) and non phototoxic (PIF < 2). Our study demonstrated the anti inflammatory activity of VCO by suppressing inflammatory markers and protecting the skin by enhancing skin barrier function. This is the first report on anti-inflammatory and skin protective benefits of VCO . Overall, the results warrant the use of VCO in skin care formulations.

Authors

  • Sandeep R Varma
    Department of Cell Biology, Discovery Sciences Group, Research and Development Centre, The Himalaya Drug Company, Makali, Bangalore 562 162, India.
  • Thiyagarajan O Sivaprakasam
    Department of Cell Biology, Discovery Sciences Group, Research and Development Centre, The Himalaya Drug Company, Makali, Bangalore 562 162, India.
  • Ilavarasu Arumugam
    Analytical Development, Research and Development Centre, The Himalaya Drug Company, Makali, Bangalore 562 162, India.
  • N Dilip
    Department of Cell Biology, Discovery Sciences Group, Research and Development Centre, The Himalaya Drug Company, Makali, Bangalore 562 162, India.
  • M Raghuraman
    Department of Cell Biology, Discovery Sciences Group, Research and Development Centre, The Himalaya Drug Company, Makali, Bangalore 562 162, India.
  • K B Pavan
    Department of Cell Biology, Discovery Sciences Group, Research and Development Centre, The Himalaya Drug Company, Makali, Bangalore 562 162, India.
  • Mohammed Rafiq
    Department of Cell Biology, Discovery Sciences Group, Research and Development Centre, The Himalaya Drug Company, Makali, Bangalore 562 162, India.
  • Rangesh Paramesh
    Chief Scientific Officer, Research and Development Centre, The Himalaya Drug Company, Makali, Bangalore 562 162, India.

Keywords

No keywords available for this article.